Skip to main content
. 2023 Mar 1;12(5):784. doi: 10.3390/cells12050784

Figure 3.

Figure 3

Glucocorticoid receptor expression in different cancer tissue types (A). (B) Immunostaining characteristics of GR using two commercially available antibodies (HPA004248: Cat#HPA004248, Atlas Antibodies; CAB010435: Cat#sc-8992, Santa Cruz Biotechnology). (C) Glucocorticoid receptor expression in female and male breast cancers; (D) GR encoding NR3C1 gene expression in primary vs. metastatic and in different subtypes of breast cancer cells. **: p < 0.01; ns: not significant.